[
    [
        {
            "time": "",
            "original_text": "医药行业2021年度投资策略报告：“疫”后起航 乘“策”而行",
            "features": {
                "keywords": [
                    "医药行业",
                    "2021年度",
                    "投资策略",
                    "疫后",
                    "政策"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 10,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 3,
                "Headline_Structure": 8,
                "Source_Recency": 2
            }
        },
        {
            "time": "",
            "original_text": "巨头集体嗨了！这些指数创多年新高！机构：坚定看多！",
            "features": {
                "keywords": [
                    "巨头",
                    "指数",
                    "新高",
                    "机构",
                    "看多"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 9,
                "Importance": 7,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 10,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 4
            }
        },
        {
            "time": "",
            "original_text": "年度公司 | 重金跨界护肤品，华熙生物要守住“玻尿酸一哥”得打一场硬仗",
            "features": {
                "keywords": [
                    "年度公司",
                    "华熙生物",
                    "玻尿酸",
                    "护肤品",
                    "竞争"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "消费品",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        }
    ]
]